跳至主要内容
临床试验/2023-508896-35-00
2023-508896-35-00招募中4 期

Live birth after additional tubal flushing with oil-based contrast versus no additional flushing: a randomised, multicentre, parallel group pragmatic trial in infertile women with at least one patent tube at Hysterosalpingo-foam sonography

Antwerp University Hospital14 个研究点 分布在 1 个国家目标入组 736 人开始时间: 2024年7月12日最近更新:
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
736
试验地点
14
主要终点
the occurrence of live birth, counting from the first day of the last menstrual cycle in which the patient conceives within 6 months after Hyfosy.

研究概览

简要总结

To determine if the additional tubal flushing with oil-based contrast after undergoing Hyfosy significantly improves the occurrence rate of live birth, counting from the first day of the last menstrual cycle in which the patient conceives within 6 months after Hyfosy compared to no additional flushing after undergoing Hyfosy.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Intervention with IMP versus control during Hyfosy
盲法
None

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
性别
Female
接受健康志愿者

入选标准

  • Infertile women undergoing Hyfosy as part of the fertility workup. Women will be eligible if they (1) are ≥ 18 years and < 40 years
  • (2) have infertility defined as: lack of conception despite 12 months of unprotected intercourse OR; if they are taking part in a donor sperm insemination programme: three cycles of donor insemination without pregnancy OR; in case of treated ovulation disorder: three ovulatory ovulation induction cycles without pregnancy
  • (3) have tubal patency of at least one Fallopian tube on Hyfosy

排除标准

  • known iodine allergy
  • no Belgian national number (RRN/INS)
  • allergy to poppy seed oil
  • ovulation disorders defined as less than eight menstrual cycles per year who did not have three ovulatory cycles after ovulation induction
  • contra-indication to have tubal patency testing according to the site’s indication
  • active thyroid disorders
  • untreated subclinical hypothyroidism (TSH>2.5mIU/L) in case of auto-immune thyroid disease
  • uterine surgery in the past two months before Hyfosy
  • a male partner (if applicable) with a post-wash Total Motile Sperm Count (TMC) < 1x106 and/or TMC < 3x106 in the native sperm analysis [TMC is defined as volume X concentration X (A* (progressive) + B* (non progressive) motility in %) divided by 100] OR with a history suspect of severe male factor infertility if no sperm sample is available at time of randomisation (*A+B when A,B,C is used (WHO 2010) A+B+C when A,B,C, D is used (WHO 2021))
  • an indication for IVF defined as patients who are advised to go to IVF immediately because of bilateral tubal block, severe male factor infertility, unsolved anovulatory problems, endometriosis with residual functional problems”

结局指标

主要结局

the occurrence of live birth, counting from the first day of the last menstrual cycle in which the patient conceives within 6 months after Hyfosy.

the occurrence of live birth, counting from the first day of the last menstrual cycle in which the patient conceives within 6 months after Hyfosy.

次要结局

未报告次要终点

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Diane De Neubourg

Scientific

Antwerp University Hospital

研究点 (14)

Loading locations...

相似试验